Saratoga Research & Investment Management Purchases New Stake in Thermo Fisher Scientific Inc (TMO)

Saratoga Research & Investment Management purchased a new stake in Thermo Fisher Scientific Inc (NYSE:TMO) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,376 shares of the medical research company’s stock, valued at approximately $260,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Proficio Capital Partners LLC lifted its position in shares of Thermo Fisher Scientific by 71.5% during the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares in the last quarter. Chicago Partners Investment Group LLC bought a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $108,000. Cribstone Capital Management LLC lifted its position in shares of Thermo Fisher Scientific by 8.7% during the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after buying an additional 50 shares in the last quarter. Shine Investment Advisory Services Inc. bought a new position in shares of Thermo Fisher Scientific during the 2nd quarter worth approximately $113,000. Finally, Ropes Wealth Advisors LLC lifted its position in shares of Thermo Fisher Scientific by 15.8% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 97 shares in the last quarter. 83.78% of the stock is currently owned by institutional investors and hedge funds.

Thermo Fisher Scientific Inc (TMO) opened at $190.17 on Friday. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $201.20. The firm has a market cap of $76,030.00, a P/E ratio of 20.78, a P/E/G ratio of 1.73 and a beta of 1.08. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same period in the previous year, the business earned $2.03 EPS. Thermo Fisher Scientific’s revenue was up 13.9% compared to the same quarter last year. equities analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be paid a $0.15 dividend. The ex-dividend date is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio is 10.19%.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/11/18/saratoga-research-investment-management-purchases-new-stake-in-thermo-fisher-scientific-inc-tmo.html.

In related news, VP Seth H. Hoogasian sold 4,140 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $177.80, for a total value of $736,092.00. Following the completion of the transaction, the vice president now directly owns 25,518 shares in the company, valued at approximately $4,537,100.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Peter E. Hornstra sold 3,894 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the transaction, the vice president now owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The disclosure for this sale can be found here. Insiders sold a total of 60,420 shares of company stock valued at $11,308,477 over the last quarter. 0.49% of the stock is owned by company insiders.

Several equities analysts have commented on TMO shares. Leerink Swann lifted their target price on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price target on the stock in a report on Thursday, September 21st. Bank of America Corporation reaffirmed a “buy” rating and issued a $210.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. Finally, Deutsche Bank AG set a $226.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $205.71.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply